Evoke Pharma Inc Quarterly Operating Income (Loss) in USD from Q3 2012 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Evoke Pharma Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2012 to Q2 2024.
Evoke Pharma Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.22M, a 31.4% increase year-over-year.
Evoke Pharma Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$6.22M, a 17.8% increase year-over-year.
Evoke Pharma Inc annual Operating Income (Loss) for 2023 was -$7.43M, a 4.56% increase from 2022.
Evoke Pharma Inc annual Operating Income (Loss) for 2022 was -$7.79M, a 4.48% increase from 2021.
Evoke Pharma Inc annual Operating Income (Loss) for 2021 was -$8.15M, a 37.5% increase from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$6.22M	-$1.22M	+$561K	+31.4%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	-$6.78M	-$1.5M	+$654K	+30.3%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	-$7.43M	-$1.89M	-$178K	-10.4%	Oct 1, 2023	Dec 31, 2023	10-K/A	2024-05-14
Q3 2023	-$7.25M	-$1.6M	+$309K	+16.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	-$7.56M	-$1.78M	+$328K	+15.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	-$7.89M	-$2.16M	-$104K	-5.07%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14
Q4 2022	-$7.79M	-$1.71M	-$162K	-10.5%	Oct 1, 2022	Dec 31, 2022	10-K/A	2024-05-14
Q3 2022	-$7.62M	-$1.91M	-$67.7K	-3.67%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$7.56M	-$2.11M	+$56.4K	+2.6%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$7.61M	-$2.05M	+$539K	+20.8%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$8.15M	-$1.55M	+$662K	+30%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-21
Q3 2021	-$8.81M	-$1.84M	+$235K	+11.3%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	-$9.05M	-$2.17M	+$4.8M	+68.9%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021	-$13.8M	-$2.59M	-$797K	-44.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	-$13M	-$2.21M	-$785K	-55.1%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-08
Q3 2020	-$12.3M	-$2.08M	-$443K	-27.1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	-$11.8M	-$6.96M	-$4.84M	-228%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	-$6.98M	-$1.79M	+$176K	+8.95%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q4 2019	-$7.15M	-$1.42M	+$344K	+19.5%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-11
Q3 2019	-$7.5M	-$1.64M	-$114K	-7.49%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-10
Q2 2019	-$7.38M	-$2.12M	+$182K	+7.91%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	-$7.57M	-$1.97M	+$448K	+18.5%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-12
Q4 2018	-$8.01M	-$1.77M	+$891K	+33.5%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-12
Q3 2018	-$8.91M	-$1.52M	+$2.18M	+58.9%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	-$11.1M	-$2.31M	+$583K	+20.2%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	-$11.7M	-$2.42M	-$437K	-22.1%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	-$11.2M	-$2.66M	-$335K	-14.4%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-06
Q3 2017	-$10.9M	-$3.7M	-$1.53M	-70.6%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-13
Q2 2017	-$9.36M	-$2.89M	+$8.26K	+0.29%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	-$9.37M	-$1.98M	+$1.17M	+37.2%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-14
Q4 2016	-$10.5M	-$2.32M	+$227K	+8.89%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-07
Q3 2016	-$10.8M	-$2.17M	+$488K	+18.4%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14
Q2 2016	-$11.3M	-$2.9M	+$267K	+8.43%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	-$11.5M	-$3.15M	+$292K	+8.49%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-15
Q4 2015	-$11.8M	-$2.55M	+$363K	+12.5%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-15
Q3 2015	-$12.2M	-$2.66M	+$1.16M	+30.5%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	-$13.3M	-$3.16M	+$327K	+9.37%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-15
Q1 2015	-$13.7M	-$3.45M	-$523K	-17.9%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-11
Q4 2014	-$13.2M	-$2.91M	-$1.33M	-84.4%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-10
Q3 2014	-$11.8M	-$3.82M	-$3.34M	-687%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-12
Q2 2014	-$8.48M	-$3.49M	-$3.29M	-1617%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-13
Q1 2014	-$5.19M	-$2.92M	-$2.59M	-780%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-14
Q4 2013	-$2.6M	-$1.58M			Oct 1, 2013	Dec 31, 2013	10-K	2015-03-04
Q3 2013		-$486K	-$7.84K	-1.64%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-13
Q2 2013		-$203K			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-13
Q1 2013		-$332K			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-13
Q3 2012		-$478K			Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.